药物开发过程:提高效率和成本效益 328条(本栏目收费,不能显示细节,电话13136136841)
Procardia XL, 185-186 186
Product leadership, 41 41
Product liability, 46-55 55
basis in drug development, 47-49 49
and drug development, 52-53 53
and the manufacturer, 49-52 52
Pulsatile delivery, 191 191
Quantitative Structure Pharmacokinetic Relationship (QSPR), 222-223 223
Receptor-based models, 241 241
Regulatory process in Japan, 354-361 361
Remifentanil, 302-304 304
Remote data entry (RDE), 347 347
Research and development balance between, 85-86 86
costs, 69-71, 80-81, 83-85 85
factors affecting, 86-101 101
differences between, 81-83 83